DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) and its subsidiary, Macrophage Therapeutics, Inc., today announced that four presentations of Manocept™ data from Kaposi’s Sarcoma (KS) studies are scheduled at the 18th International Workshop on Kaposi’s Sarcoma Herpesvirus (KSHV) and Related Agents in Hollywood, Florida from June 30 - July 3, 2015. This research highlights a very likely new approach to the origin of KS supported by preclinical and clinical imaging studies.
Help employers find you! Check out all the jobs and post your resume.
